German drugmaker Grünenthal has named Maren Thurow as its new vice president and head of global communications, stepping into the role at a time of significant business expansion and leadership change. She succeeds Florian Dieckmann, who had led the company’s communications function since 2021.
Ms Thurow, who joined the company three years ago, will now oversee communications across all of Grünenthal’s markets and lead the team from its headquarters in Aachen. She will report directly to chief executive Gabriel Baertschi.
The appointment comes as Grünenthal continues to reshape its portfolio and global footprint following a year of strong financial performance and major business moves. Since 2017, the company’s profitability — measured by adjusted EBITDA — has more than tripled, supported by a wave of acquisitions and a sharpened focus on late-stage research programs.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze